Shu et al. [20] did not find an increased endometrial cancer risk overall; however, they found a proportionally increased risk of serous/serous-like endometrial cancer after RRSO in BRCA1 GPV carriers until age 70 [O/E 22.2, 6.05–56.9], which could not be reproduced in BRCA2 GPV mutation carriers [O/E 6.37, 0.16–35.5]. The gene discussed is BRCA1; the disease is endometrial cancer.